By
Biosensors International Group Ltd, a maker of medical devices,
said on Wednesday that its net profit for the fiscal first quarter ended
June 30, 2012 rose 45 per cent from a year ago to US$32.63 million.
The improved performance was due to the full quarter consolidation of the results of JW Medical System Ltd (JWMS) in the first quarter, higher product revenue, licensing revenue and gain on fair value adjustments for the derivatives.
Total revenue, including licensing and royalty revenue, rose 51 per cent from a year ago to US$86.31 million.
The management expects total revenues for thefiscal year ending March 31, 2013 to grow between 20% and 30%, driven by continued strong revenue growth from its drug-eluting stent (DES) as well as modest licensing and royalty revenue increase.
The improved performance was due to the full quarter consolidation of the results of JW Medical System Ltd (JWMS) in the first quarter, higher product revenue, licensing revenue and gain on fair value adjustments for the derivatives.
Total revenue, including licensing and royalty revenue, rose 51 per cent from a year ago to US$86.31 million.
The management expects total revenues for thefiscal year ending March 31, 2013 to grow between 20% and 30%, driven by continued strong revenue growth from its drug-eluting stent (DES) as well as modest licensing and royalty revenue increase.
Posts
No comments:
Post a Comment